M24, 1 year pictures using oral dut & topical minoxidil sulfate 8/26/2026
A user shared their experience using oral dutasteride and topical minoxidil sulfate for hair loss, noting little improvement and considering a hair transplant. Others suggested trying oral minoxidil, RU58841, microneedling, and ensuring medication is sourced from a legitimate pharmacy.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity We cooked fam? 1 Year on Dut + Oral Min after years of Fin (some mistakes made & details in comments)
The user switched from finasteride and topical minoxidil to dutasteride and oral minoxidil, experiencing some hair shedding but maintaining hair quality. Suggestions include increasing oral minoxidil dosage, considering a hair transplant, and using dermarolling, while some users recommend stopping treatment altogether.
community Results after 3 years on Fin and Min
The user has been using oral finasteride and topical minoxidil for three years, seeing some regrowth initially but mostly maintenance afterward. Suggestions for further improvement include trying dutasteride, RU58841, or a hair transplant.
community Topical Dutasteride (Switching from Oral) Proven results
Switching from oral to topical dutasteride may reduce side effects like anxiety and depression while maintaining hair health. Combining it with minoxidil, Nizoral, and dermarolling could be effective for hair preservation.
community 5 months oral 1.2mg Fin, 3mg Min. Switching to Dut. 39M
The user has been using oral finasteride and minoxidil for five months with some progress and plans to switch to dutasteride, while also considering a hair transplant for better coverage. Suggestions include adding microneedling, Nizoral shampoo, and possibly using both oral and topical treatments for improved results.
community Male baldness - tried everything - emotionally tired....
A 30-year-old man is frustrated with hair loss despite using finasteride, topical minoxidil, ketoconazole shampoo, and PRP. Suggestions include trying oral minoxidil, dutasteride, RU58841, or considering a hair transplant.
Related Research
6 / 6 results
research Comparative Evaluation of the Clinical Efficacy of PRP-Therapy, Minoxidil, and Their Combination with Immunohistochemical Study of the Dynamics of Cell Proliferation in the Treatment of Men with Androgenetic Alopecia
This study found that combining platelet-rich plasma therapy with minoxidil was more effective in treating androgenetic alopecia in men than either treatment alone.
research Drug discovery for alopecia: gone today, hair tomorrow
This review discusses current knowledge on the biological mechanisms of different types of alopecia but reports no new clinical findings; the authors highlight future research directions, especially regarding epidermal stem cells and immune pathways.
research Development of fluridil, a topical suppressor of the androgen receptor in androgenetic alopecia
In this study, using a novel topical androgen receptor suppressor, fluridil, significantly increased the percentage of growing hairs in males with androgenetic alopecia without systemic absorption or adverse side effects.
research Experimental and early investigational drugs for androgenetic alopecia
This review discusses current and emerging therapeutic strategies for androgenetic alopecia, noting limited evidence but suggesting areas such as prostaglandin analogs, PRP, and progenitor cell therapies as promising future directions.
research Biomedical Technologies for Androgenic Alopecia Treatment: Advance, Mechanism and Future Direction
This review discusses advanced biomedical technologies, such as nanotechnology and stem cell-based approaches, for treating androgenetic alopecia, detailing their benefits, current applications, and challenges, without reporting new experimental results.
research Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism
This review discusses low-level light therapy for androgenetic alopecia and female pattern hair loss, noting minimal clinical evidence on its efficacy and the need for more controlled studies.